Free Trial

Arcadia Biosciences Q1 2024 Earnings Report

Arcadia Biosciences logo
$3.98 -0.41 (-9.34%)
As of 02/21/2025 03:59 PM Eastern

Arcadia Biosciences EPS Results

Actual EPS
-$1.78
Consensus EPS
-$2.52
Beat/Miss
Beat by +$0.74
One Year Ago EPS
-$3.83

Arcadia Biosciences Revenue Results

Actual Revenue
$1.26 million
Expected Revenue
$1.20 million
Beat/Miss
Beat by +$60.00 thousand
YoY Revenue Growth
N/A

Arcadia Biosciences Announcement Details

Quarter
Q1 2024
Time
After Market Closes

Arcadia Biosciences Earnings Headlines

Arcadia Biosciences (NASDAQ:RKDA) Now Covered by StockNews.com
Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."
If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry.
Arcadia Biosciences (RKDA) Gets a Buy from Lake Street
See More Arcadia Biosciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Arcadia Biosciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Arcadia Biosciences and other key companies, straight to your email.

About Arcadia Biosciences

Arcadia Biosciences (NASDAQ:RKDA) produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

View Arcadia Biosciences Profile

More Earnings Resources from MarketBeat